Georgia vs Jordan: Life science patents granted, by technology
Georgia
31 patents
in 2023
Jordan
23 patents
in 2023
Georgia rank
25th
Jordan rank
28th
Life science patents granted, by technology over time
- Georgia
- Jordan
How they compare
Georgia currently reports 31 patents against 23 patents in Jordan, a difference of 8 patents.
That makes Georgia's figure about 1.3 times Jordan's.
The two have swapped places 3 times across 28 shared years of data; in 1994 it was Jordan ahead.
Georgia ranks 25th and Jordan ranks 28th of 65 countries.
Across the 4 decades both report, Georgia averaged higher in 3 and Jordan in 1.
Head to head by decade
| Decade | Georgia | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.6 patents | 3.4 patents | 19.2 patents | Georgia |
| 2000s | 71.33 patents | 8.67 patents | 62.67 patents | Georgia |
| 2010s | 57.9 patents | 11.3 patents | 46.6 patents | Georgia |
| 2020s | 32.25 patents | 63.5 patents | 31.25 patents | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Georgia or Jordan?
- Georgia, at 31 patents against 23 patents in Jordan as of 2023.
- What is the difference in life science patents granted, by technology between Georgia and Jordan?
- 8 patents, with Georgia ahead.
- How many years of comparable data are there for Georgia and Jordan?
- 28 years are reported by both, from 1994 to 2023.
- How do Georgia and Jordan rank globally for life science patents granted, by technology?
- Georgia ranks 25th and Jordan ranks 28th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.